Company Quick10K Filing
Quick10K
Advanced Oxygen Technologies
10-Q 2019-03-31 Quarter: 2019-03-31
10-Q 2018-12-31 Quarter: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-K 2018-06-30 Annual: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-K 2017-06-30 Annual: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-Q 2016-12-31 Quarter: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-K 2016-06-30 Annual: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-K 2015-06-30 Annual: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-Q 2014-12-31 Quarter: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-K 2014-06-30 Annual: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-Q 2013-12-31 Quarter: 2013-12-31
WY Weyerhaeuser 19,970
ARGX Argenx Se 4,660
CWT California Water Service Group 2,380
NVEE NV5 Global 759
AVRO Avrobio 498
YIN Yintech Investment Holdings 442
ATOS Atossa Genetics 24
HEB Hemispherx Biopharma 9
CLCN Creative Learning 0
BSTG Biostage 0
AOXY 2019-03-31
Part 1: Financial Information
Note 1- Organization and Line of Business
Note 2 - Summary of Significant Accounting Policies:
Note 3 - Major Customer:
Note 4 - Land and Buildings:
Note 5 - Related Party Transactions:
Note 6 - Notes Payable:
Note 7 - Shareholders' Equity:
Note 8 - Subsequent Events:
Item 2: Management's Discussion and Analysis or Plan of Operation.
Item 3. Quantitative and Qualitative Disclosures About Market Risk:
Item 4. Controls and Procedures
Part II
Item 1: Legal Proceedings
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6: Exhibits and Reports on Form 8-K
EX-31.1 e1309_ex311.htm
EX-31.2 e1309_ex312.htm
EX-32.1 e1309_ex321.htm
EX-32.2 e1309_ex322.htm

Advanced Oxygen Technologies Earnings 2019-03-31

AOXY 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

10-Q 1 e1309_10q.htm FORM 10-Q 03312019 10Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended: March 31, 2019

Or

 

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE  ACT OF 1934

 

For the transition period from: _____________ to _____________

 

ADVANCED OXYGEN TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

0-9951

 

91-1143622

(State or Other Jurisdiction

 

(Commission

 

(I.R.S. Employer

of Incorporation)

 

File Number)

 

Identification No.)

 

C/O Crossfield, Inc., 653 VT Route 12A, PO Box 189, Randolph, VT 05060

(Address of Principal Executive Offices) (Zip Code)

 

(212) 727-7085

(Registrant’s telephone number, including area code)

 

Indicate by check mark if the registrant is not required to file reports pursuant to section 13 or Section 15(d) of the Act. Yes No

 

Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “an accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

Accelerated Filer

Non Accelerated Filer

Smaller Reporting Company

Emerging Growth Company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes No

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Check one: Yes No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the last practicable date: As of April 17, 2019, there were 2,292,945 issued and outstanding shares of the registrant’s Common Stock, $.01 par value.

 

Documents incorporated by reference: None.

 

 
 
 
 

  

ADVANCED OXYGEN TECHNOLOGIES, INC.

 

Table of Contents

 

INDEX

Page

 

PART I

 

 

 

 

 

 

 

Item I:

Financial Statements (unaudited)

 

 

 

 

Condensed Consolidated Balance Sheet as of March 31, 2019 (unaudited) and June 30, 2018

 

 

3

 

 

Condensed Consolidated Statement of Operations and Other Comprehensive Income (Loss) for the three and nine months ended March 31, 2019 and March 31, 2018 (unaudited)

 

 

4

 

Condensed Consolidate Statements of Stockholders' Equity for the Nine-Months ending March 31, 2019 5

 

Condensed Consolidated Statement of Cash Flow for the nine months ended March 31, 2019 and March 31, 2018 (unaudited)

 

 

5

 

 

Notes to the Condensed Consolidated Financial Statements

 

 

7-11

 

Item 2:

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

 

12

 

Item 3:

Quantitative and Qualitative Disclosures about Market Risk

 

 

13

 

Item 4:

Controls and Procedures

 

 

13

 

 

 

 

 

 

 

PART II

 

 

 

 

 

 

 

 

 

Item 1:

Legal Proceedings

 

 

14

 

Item 2:

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

14

 

Item 3:

Defaults Upon Senior Securities

 

 

14

 

Item 4:

Mine Safety Disclosures

 

 

14

 

Item 5:

Other Information

 

 

14

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

14

 

Signature

 

 

15

 

EXHIBIT 31.1, 31.2 Certifications of Officers

 

EX 31

 

EXHIBIT 32.1, 32.2 Certifications of Officers

 

EX 32

 

EXHIBIT 101.INS XBRL Instance

 

EX 101.INS

 

EXHIBIT 101.SCH XBRL Taxonomy Extension Schema Document

 

EX 101.SCH

 

EXHIBIT 101.CAL XBRL Taxonomy Extension Calculation Document

 

EX 101.CAL

 

EXHIBIT 101.DEF XBRL Taxonomy Extension Definition Document

 

EX 101.DEF

 

EXHIBIT 101.LAB XBRL Taxonomy Extension Labels Document

 

EX 101.LAB

 

EXHIBIT 101.PRE XBRL Taxonomy Extension Presentation Document

 

EX 101.PRE

 

 

 
2
 
Table of Contents

 

PART 1: FINANCIAL INFORMATION

 

Item I: Condensed Consolidated Financial Statements for the nine-months ending March 31, 2019 (unaudited) and year ending June 30, 2018.

 

ADVANCED OXYGEN TECHNOLOGIES, INC.

AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

March 31, 2019

 

 

June 30,

2018

 

ASSETS

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

 

$ 38,584

 

 

$ 53,415

 

Property tax receivable

 

 

1,722

 

 

 

1,772

 

Total current assets

 

 

40,306

 

 

 

55,187

 

 

 

 

 

 

 

 

 

 

FIXED ASSETS

 

 

 

 

 

 

 

 

Land

 

 

607,197

 

 

 

632,712

 

TOTAL ASSETS

 

$ 647,503

 

 

$ 687,899

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Accounts payable

 

$ 725

 

 

$ 750

 

Taxes payable

 

 

26,485

 

 

 

40,269

 

Notes payable, current portion

 

 

144,154

 

 

 

143,422

 

Advances from a related party

 

 

119,902

 

 

 

112,255

 

Total current liabilities

 

 

291,266

 

 

 

296,696

 

 

 

 

 

 

 

 

 

 

Notes Payable

 

 

65,941

 

 

 

83,446

 

 

 

 

 

 

 

 

 

 

Total Long -Term Liabilities

 

 

65,941

 

 

 

83,446

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

357,207

 

 

 

380,142

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY-

 

 

 

 

 

 

 

 

Convertible preferred stock, Series 2, par value $0.01; authorized 10,000,000 shares; issued and outstanding 5,000 at March 31, 2019 and June 30, 2018

 

 

50

 

 

 

50

 

Convertible preferred stock, Series 3, par value $0.01; authorized 1,670,000 shares; zero shares issued and outstanding

 

 

-

 

 

 

-

 

Convertible preferred stock, Series 5; no par value, 1 share authorized, zero shares issued and outstanding, respectively.

 

 

-

 

 

 

-

 

Common stock, par value $0.01; At March 31, 2019 and June 30, 2018, authorized 60,000,000 shares; issued and outstanding 2,292,945 shares.

 

 

22,929

 

 

 

22,929

 

Additional paid-in capital

 

 

20,953,991

 

 

 

20,953,991

 

Accumulated Other Comprehensive Income

 

 

41,053

 

 

 

63,139

 

Accumulated deficit

 

 

(20,727,727 )

 

 

(20,732,352 )

TOTAL STOCKHOLDERS EQUITY

 

 

290,296

 

 

 

307,757

 

TOTAL LIABILITIES AND STOCKHOLDERS EQUITY

 

$ 647,503

 

 

$ 687,899

 

 

See accompanying notes to condensed consolidated financial statements.

 

 
3
 
Table of Contents

  

ADVANCED OXYGEN TECHNOLOGIES, INC.
AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

 

For the three months ended March 31,

 

For the nine months ended March 31,

 

 

2019

2018

 

2019

 

 

2018

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

Real Estate Rentals

$
9,528
$
10,215

 

$ 28,689

 

 

$ 29,849

 

 

 

 

 

 

 

 

Total Revenues

9,528
10,215

 

28,689

 

 

29,849

 

 

 

 

 

 

 

 

 

 

Costs and Expenses

 

 

 

 

 

 

 

 

General & Administrative

1,316
1,183

 

 

4,492

 

 

 

4,393

 

Professional expenses

2,500
2,000

 

 

11,000

 

 

 

11,500

 

-

 

 

 

 

 

 

Total Operating Expenses

3,816
3,183

 

 

15,492

 

 

 

15,893

 

 

 

 

 

 

 

 

 

 

Income (Loss) from operations before other income (expenses)

5,712
7,032

 

13,197

 

 

13,956

 

Other income (expenses)

 

 

 

 

 

 

 

 

Interest Expense

(1,014
)
(1,454

)

 

(3,227

)

 

 

(4,550

)

 Income before Income Taxes

4,698
5,578

 

9,970

 

 

9,406

 

 

 

 

 

 

 

 

Income Taxes Expense (Benefit)

5,536
1,892

 

 

5,345

 

 

5,380

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

$
(838
) $
3,686

$ 4,625

 

$ 4,026

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding

2,292,945
2,292,945

 

2,292,945

 

 

 

2,292,945

 

 Dilutive average weighted number of common shares

2,292,945

2,302,945

 

 

2,302,945

 

 

 

2,302,945

 

Basic Net Income (loss) per Share

$
(0.0004
) $
0.0016

$ 0.0020

 

$ 0.0018

Dilutive Net Income (loss) per Share

$
(0.004
) $
0.0016

$ 0.0020

 

$ 0.0018

 

 

 

 

 

 

 

 

 

COMPREHENSIVE INCOME

 

 

 

 

 

 

 

 

Other Income (Loss)

 

 

 

 

 

 

 

 

Translation Adjustments

$
(11,166
) $
16,557

$ (22,086 )

 

$

42,928

Total Comprehensive Income (Loss)

$
(12,004
) $
20,243

$ (17,461

)

 

$ 46,954

 

See accompanying notes to condensed consolidated financial statements.

 

 
4
 
Table of Contents
 


ADVANCED OXYGEN TECHNOLOGIES, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

 Nine-Month Period Ending March 31, 2019

 

 

Preferred Stock

 

 

 

 

 

 

Convertible Series 2,
par value $0.01, $25,000
liquidating Preference

 

 

Common
Stock  

 

 

Additional
Paid In
Capital

 

 

Accumulated Deficit

 

 

Other Comprehensive Income

 

 

Total Stockholders' Equity

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Amount

 

 

Amount

 

 

Amount

 

 

Amount

 

Balance at June 30, 2018

 

 

5,000

 

 

 

50

 

 

 

2,292,945

 

 

 

22,929

 

 

 

20,953,991

 

 

 

(20,732,352 )

 

 

63,139

 

 

 

307,7857

 

Net Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,689

 

 

 

 

 

 

 

2,689

 

Foreign Currency Translation Adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,761 )

 

 

(2,761 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at September 30, 2018

 

 

5,000

 

 

 

50

 

 

 

2,292,945

 

 

 

22,929

 

 

 

20,953,991

 

 

 

(20,729,663 )

 

 

60,378

 

 

 

307,685

 

Net Income

 

2,774

 

 

 

 

 

 

2,774

 

Foreign Currency Translation Adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,159
)

 

 

(8,159
)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2018

 

 

5,000

 

 

 

50

 

 

 

2,292,945

 

 

 

22,929

 

 

 

20,953,991

 

 

 

(20,726,889 )

 

 

52,209

 

 

 

302,300

 

Net Income

(838 ) (838 )

Foreign Currency Translation Adjustment

(11,166 ) (11,166 )

Balance at March 31, 2019

5,000 50 2,292,945 22,929 20,953,991 (20,727,727 ) 41,053 290,296

 

 See accompanying notes to the consolidated financial statements. 

 

 
5

Table of Contents

ADVANCED OXYGEN TECHNOLOGIES, INC. 

AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited) 

 

 

 

For the

Nine Months Ended

 March 31,

 

 

 

2019

 

 

2018

 

Cash flows from operating activities

 

 

 

 

 

 

Net income (loss)

 

$ 4,625

 

 

$ 4,026

Adjustments to reconcile net income (loss) to net cash:

 

 

 

 

 

 

 

 

Expenses paid on behalf of a related party

 

 

14,350

 

 

 

16,755

 

Changes in operating assets and liabilities:

Accounts payable

 

 

(25

)

 

 

(1,181 )

Prepaid Expenses

- (525 )

Taxes payable

 

 

(12,427 )

 

 

5,139

Net cash provided by (used in) operating activities

 

 

6,523

 

 

24,214

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities:

 

 

 

 

 

 

 

 

Repayment of long term and related party debt

 

 

(19,483 )

 

 

(26,095 )

Net cash provided by (used in) financing activities

 

 

(19,483 )

 

 

(26,095 )

 

 

 

 

 

 

 

 

 

Change due to FX Translation

 

 

(1,871 )

 

 

4,148

 

 

 

 

 

 

 

 

 

 

Net Increase in Cash

 

 

(14,831 )

 

 

2,267

 

 

 

 

 

 

 

 

 

Cash at beginning of the period

 

$ 53,415

 

 

$ 50,331

 

Cash at end of period

 

$ 38,584

 

 

$ 52,598

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cashflow Information

 

 

 

 

 

 

 

 

Cash paid for Interest

 

 

3,227

 

 

 

4,550

 

 

See accompanying notes to condensed consolidated financial statements.

 

 
6
 
Table of Contents

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1- ORGANIZATION AND LINE OF BUSINESS

 

Organization and Basis of Presentation:

 

Advanced Oxygen Technologies Inc, (“the Company”), was incorporated in Delaware in 1981 under the name Aquanautics Corporation and was, from 1985 until May 1995, a startup stage specialty materials company producing new oxygen control technologies. From May of 1995 through December of 1997 the Company had minimal operations and was seeking funding for operations and companies to which it could merge or acquire. In March of 1998 the Company began operations again in California. From 1998 through 2000, the business produced and sold CD- ROMS for conference events, advertisement sales on the CD’s, database management and event marketing all associated with conference events. From 2000 through March of 2003, the business consisted solely of database management. From 2003 through April 2005, the business operations were derived totally from the Company’s wholly owned business, IP Service, ApS, a Danish IP security vulnerability company (“IP Service”). Since then, business operations have been solely derived from real estate rentals in Denmark through its wholly owned subsidiary.

 

The results of operations for the nine-months ended March 31, 2019 are not necessarily indicative of the results to be expected for the year ending June 30, 2019. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes related thereto for the years ended June 30, 2018 and 2017 included in Form 10-K filed with the SEC.

 

Lines of Business:

 

The Company, through its wholly owned subsidiary Anton Nielsen Vojens ApS owns income producing commercial real estate leased until 2026. The real estate consists solely of the land with no buildings or improvements (Land). All improvements on the Land are those of the tenant.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

 

Revenue recognition of rental income:

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), to update the financial reporting requirements for revenue recognition. Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. It supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. This guidance became effective for the Company beginning on January 1, 2018, and entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. We adopted this standard using the modified retrospective approach on July 1, 2018.

 

In preparation for adoption of the standard, we have implemented internal controls and completed our impact assessment of implementing this guidance. We have evaluated each of the five steps in Topic 606, which are as follows: 1) identify the contract with the customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) performance obligations are satisfied.

 

Revenue was not affected materially in any period due to the adoption of ASC Topic 606 because: (1) we identified similar performance obligations under ASC Topic 606 as compared with deliverables and separate units of account previously identified; (2) we determined the transaction price to be consistent; and (3) we recorded revenue at the same point in time, upon delivery under both ASC Topic 605 and ASC Topic 606, as applicable under the terms of the contract with the customer. Additionally, the accounting for fulfillment costs or costs incurred to obtain a contract were not affected materially in any period due to the adoption of Topic 606.

 

There are also certain considerations related to accounting policies, business processes and internal control over financial reporting that are associated with implementing Topic 606. We have evaluated our policies, processes, and control framework for revenue recognition, and identified and implemented the changes needed in response to the new guidance.

 

Lastly, disclosure requirements under the new guidance in Topic 606 have been significantly expanded in comparison to the disclosure requirements under the current guidance, including disclosures related to disaggregation of revenue into appropriate categories, performance obligations, the judgments made in revenue recognition determinations, adjustments to revenue which relate to activities from previous quarters or years, any significant reversals of revenue, and costs to obtain or fulfill contracts. We have designed and implemented the appropriate controls over gathering and reporting the information as required under Topic 606, in order to support the expanded disclosure requirements.

 

 
7
 
Table of Contents

 

Property Plant and Equipment:

 

Land and buildings are recognized at cost. Land is carried at cost less accumulated impairment losses.

 

Foreign currency translation:

 

Foreign currency transactions are translated applying the current rate method. Assets and liabilities are translated at current rates. Stockholders’ equity accounts are translated at the appropriate historical rates and revenue and expenses are translated at weighted average rates for the year. Exchange rate differences that arise between the rate at the transaction date and the one in effect at the payment date, or at the balance sheet date, are recognized in the income statement.

 

Income Taxes:

 

The Company accounts for income taxes under the asset and liability method of accounting. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is required when it is less likely than not that the Company will be able to realize all or a portion of its deferred tax assets. Because it is doubtful that the net operating losses of recent years will ever be used, a valuation allowance has been recognized equal to the tax benefit of net operating losses generated.

 

Earnings per Share:

 

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. As of March 31, 2019 and March 31, 2018 there were 10,000 and 10,000 potential dilutive shares respectively that need to be considered as common share equivalents.

 

Cash and Cash Equivalents:

 

For purposes of the statement of cash flows, the Company considers all highly-liquid investments purchased with original maturities of three-months or less to be cash equivalents.

    

The Company maintains its cash in bank deposit accounts which, at March 31, 2019 did not exceed federally insured limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on such amounts.

    

Estimates:

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk:

 

Financial instruments that potentially subject the Company to major credit risk consist principally of a single subsidiary of Anton Nielsen Vojens ApS.

 

 
8
 
Table of Contents

 

Recently Issued Accounting Standards:

   

On January 5, 2017 FASB issued Accounting Standards Update (“ASU”) 2017-01, Clarifying the Definition of a Business. This update amended the definition of a business, which is fundamental to the determination of whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. That distinction impacts how the acquisition is treated in the financial statements, for instance, whether deal costs are capitalized or expensed. The primary goal of ASU 2017-01 was to narrow that definition, which is generally expected to result in fewer transactions qualifying as business combinations. The Company is in the process of evaluating the impact of this new guidance.

 

In February 2016, the FASB issued ASU No. 2016-02 - Leases (Topic 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either financing or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. The standard is effective on January 1, 2019, however early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance.

 

In February 2015, the FASB issued Accounting Standards Update No. 2015-02 (ASU 2015-02) “Consolidation (Topic 810): Amendments to the Consolidation Analysis.” ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We do not anticipate that the adoption of ASU 2015-02 will have any impact on our condensed consolidated financial statements.

 

Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company's present or future financial statements.

 

NOTE 3 - MAJOR CUSTOMER:

 

The Company's subsidiary, Anton Nielsen Vojens, ApS has sales to one customer who is a non related party. For the period ending March 31, 2019 and March 31, 2018 the major customer concentrations were as follows:

 

 

 

Percent of Sales for the

Period ending March 31,

 

Customer

 

2019

 

 

2018

 

Circle K Denmark A/S, Formerly Statoil A/S

 

 

100 %

 

 

100 %

 

 

 

 

 

 

 

 

 

Total Sales from Major Customers

 

 

100 %

 

 

100 %

 

NOTE 4 - LAND AND BUILDINGS:

 

The Land owned by the Company's wholly owned subsidiary constitutes the largest asset of the Company. During the nine-month period ending March 31, 2019 the Company recorded a decrease in the carrying value of the Land of $(25,514) due to the currency translation difference. The carrying value of the Land of the Company was as follows:

 

 

 

 Carrying Value of

Land at

 

 

 

March 31, 2019

 

June 30, 2018

 

 

 

 

 

 

 

US Dollars

 

$ 607,197

 

$ 632,712

 

 

 
9
 
Table of Contents

 

NOTE 5 - RELATED PARTY TRANSACTIONS:

 

Crossfield, Inc., a company of which the CEO, Robert Wolfe is an officer and director, has made advances to the Company which are not collateralized, non-interest bearing, and payable upon demand, however, the Company did not expect to make payment within one year. At March 31, 2019 and March 31, 2018 the Company had a balance of $119,902 and $110,343 respectively. During the nine-month period ended March 31, 2019 and March 31, 2018 the Company was advanced $14,350 and $16,755 respectively.

 

NOTE 6 - NOTES PAYABLE:

 

During 2006, the Company issued a promissory note ("Note") for $650,000, payable to the Borkwood Development Ltd, a previous shareholder of the Company ("Seller"), payable and amortized monthly and carrying an interest at 5% per year. The Company has the right to prepay the note at any time with a notice of 14 days. To secure the payment of principal and interest the Sellers will receive a perfect lien and security interest in the Shares in the company ANV until the note with accrued interest is paid in full, and, 2) In the case that the Note has not been repaid within 12 months from the day of closing the Sellers have the right to convert the debt to common stock of Advanced Oxygen Technologies, Inc. in an amount of non-diluted shares calculated on the conversion Date, equal to the lesser of : a) Six hundred and Fifty thousand (650,000) or the Purchase Price minus the principal payments made by the buyer, whichever is greater, divided by the previous ten day closing price of AOXY as quoted on the national exchange, or b) Fifteen million shares, whichever is lesser. The Note has been extended until July 1, 2019, prior to period end and interest waived through the period ending June 30, 2019. Due to the extension, the note is not in default and therefore not convertible as of June 30, 2018. The balance on the note as of March 31, 2019 and June 30, 2018 was $127,029.

 

The Company has a note payable with a bank ("Note B"). The original amount of Note B was kr 1,132,000 Danish Krone (kr). Note B is secured by the subsidiary's real estate, with a 5.00% interest rate and 4.7 years left on the term. The balance on the note as of March 31, 2019 was $83,066. During the nine-month period ended March 31, 2019, the Company paid $12,748 in principal payments and $3,159 in interest.

 

The Company's commitments and contingencies are $132,273 for the remainder of the year ending June 30, 2019 and $20,977 for the years 2020 through 2025 with a total of $210,095. The amounts stated reflect the Company's commitments in the currencies that those commitments were made and the amounts are an estimate of what the US dollar amount would be if the currency rates did not change. The Company's commitment for bank payments would be $5,244 for the next quarter year, and $20,977 per year thereafter for another 5 years.

 

The amounts stated in this note reflect the Company's commitments in the currencies that those commitments were made and the amounts are an estimate of what the US dollar amount would be if the currency rates did not change going forward.

 

NOTE 7 - SHAREHOLDERS' EQUITY:

 

Common Stock:

 

Pursuant to a Certificate of Amendment to our Certificate of Incorporation filed with the State of Delaware and effective as of December 8, 2014, the Company (effected a reverse stock split of all the outstanding shares of our common stock at an exchange ratio of one for twenty (1:20) and changed the number our authorized shares of common stock, par value $0.01 per share, from 90,000,000 to 60,000,000 while maintaining the number of authorized shares of preferred stock, par value $0.01 per share, at 10,000,000. As a result, the 45,853,585 shares of common stock outstanding at December 7, 2014 had been reduced to 2,292,945 shares of common stock (taking into account the rounding up of fractional share interests).

 

 
10
 
Table of Contents

 

Preferred Stock:

 

The Company is authorized to issue 10,000,000 shares of $0.01 par value of series 2 convertible preferred stock. The Company may issue any class of preferred shares in series. The board of directors has the authority to establish and designate series and to fix the number of shares included in each such series. Each Series 2 preferred share is convertible into two shares of common stock at the option of the holder.

 

Series 2 Convertible Preferred Stock:

 

Each Series 2 preferred share also includes one warrant to purchase two common shares for $5.00. The warrants are exercisable over a three-year period. In the event of the liquidation of the Company, holders of Series 2 preferred stock would be entitled to receive $5.00 per share, plus any unpaid dividends declared on the Series 2 preferred stock from the funds remaining after the Company's creditors, including directors, have been paid. There have been no dividends declared. There are 177,000 Series 2 Convertible Preferred shares designated. During November 1997, 172,000 shares of Series 2 preferred stock were converted into 344,000 shares of the Company's common stock. As of June 30, 2018, there are 5,000 shares issued, which are convertible into 2 common shares. There are no warrants outstanding that have been issued in connection with these preferred shares.

 

Series 3 Convertible Preferred Stock:

 

The Company has designated 1,670,000 shares of series 3 convertible preferred stock with a par value $0.01. Each share automatically converts on March 2, 2000 into either (a) one (1) share of the Company's common stock if the average closing price of the common stock during the ten trading days immediately prior to March 1, 2000 is equal to or greater than sixty-six cents ($0.66) per share, or (b) one and one-half (1 1/2) shares of common stock if the average closing price of the common stock during the ten trading days immediately prior March 1, 2000 is less than sixty-six cents ($0.66) per share. There are zero shares issued and outstanding at March 31, 2019.

 

Series 5 Convertible Preferred Stock:

 

The Company has designated 1 share of series 5 convertible preferred stock, no par value. There is 1 Series 5 Convertible Preferred shares designated. The shares are collectively convertible to common stock of the Company on March 5, 2004, in an amount equal to the greater of a.) 290,000 shares divided by the ten day closing price, prior to the date of acquisition of IPS, of the Company's common stock as quoted on the national exchange and not to exceed twenty million shares, or b.) six million shares. There are zero shares issued and outstanding at March 31, 2019.

 

NOTE 8 - SUBSEQUENT EVENTS:

 

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report. There are no material subsequent events to report.

 

 
11
 
Table of Contents

 

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

 

The following should be read in conjunction with our Consolidated Financial Statements and the notes thereto included in the Financial Statements.

 

FORWARD LOOKING STATEMENTS:

 

Certain statements contained in this report, including statements concerning the Company's future and financing requirements, the Company's ability to obtain market acceptance of its products and the competitive market for sales of small production business and other statements contained herein regarding matters that are not historical facts, are forward looking statements; actual results may differ materially from those set forth in the forward looking statements, which statements involve risks and uncertainties, including without limitation to those risks and uncertainties set forth in any of the Company's Registration Statements under the heading "Risk Factors" or any other such heading. In addition, historical performance of the Company should not be considered as an indicator for future performance, and as such, the future performance of the Company may differ significantly from historical performance.

 

Revenues: Revenues from operations for the three-month period ending March 31, 2019 and March 31, 2018 were $9,528 and $10,215 respectively, and the revenues from operations for the nine-month period ending March 31, 2019 and March 31, 2018 were $28,689 and $29,849 respectively. The revenues were attributable to operations of the Company's wholly owned subsidiary Anton Nielsen Vojens. The fluctuation was due to currency fluctuations.

 

Selling, general and administrative expenses: G&A expenses for the three-month period ending March 31, 2019 and March 31, 2018 were $1,316 and $1,183 respectively, and the G&A expenses for the nine-month period ending March 31, 2019 and March 31, 2018 were $4,492 and $4,393 respectively. The expenses are mainly attributable to ANV's normal operations and the Company's SEC compliance and the fluctuations are attributable to currency fluctuations.

 

Professional expenses: Professional expenses for the three-month period ending March 31, 2019 and March 31, 2018 were $2,500 and $2,000 respectively, and the professional expenses for the nine-month period ending March 31, 2019 and March 31, 2018 were $11,000 and $11,500 respectively. The expenses are mainly attributable to the Company's independent auditors.

 

Interest expense: Interest expense for the three-month period ending March 31, 2019 and March 31, 2018 was $1,014 and $1,454 respectively. Interest expense for the nine-month period ending March 31, 2019 and March 31, 2018 was $3,227 and $4,550 respectively. Interest expenses for 2019 are lower primarily due to the currency fluctuations and the reduction of debt.

 

Net income (loss) attributed to common stockholders: Net income (loss) attributed to common stockholders was $(838) or $(0.0004) per share for the three-month period ending March 31, 2019 as compared to $3,686 or $0.0016 per share for the three-month perioding ending March 31, 2018. Net income (loss) attributed to common stockholders was $4,625 or $0.0020 per share for the nine-month period ending March 31, 2019 as compared to $4,026 or $0.0018 per share for the nine-month period ending March 31, 2018. The fluctuations are mainly attributable to professional fees and currency fluctuations.

 

Liquidity and capital resources: At March 31, 2019 and June 30, 2018, the Company had cash and cash equivalents of $38,584 and $53,415 respectively. At March 31, 2019 and June 30, 2018, the Company had a working capital deficit of $250,960 and $241,509 respectively. The change in cash is primarily associated with currency fluctuations, and the decrease in the working capital deficit is primarily due to payment of debt and normal operations.

 

Net cash provided by (used in) operating activities for nine-month period ending March 31, 2019 and March 31, 2018 was $6,523 and $24,214, respectively. The net cash used by operating activities was primarily due to the operations of ANV and the payment of ANV taxes.

 

Net cash provided from (used for) financing activities for nine-months period ending March 31, 2019 and March 31, 2018 was $(19,483) and $(26,095) respectively. Net cash provided from or used for financing activities for both periods is related to the company's borrowings from banks, officers and directors, and the repayment of debt.

 

OFF BALANCE SHEET ARRANGEMENTS:

 

We do not currently have any off balance sheet arrangements.

 

 
12
 
Table of Contents

 

ACQUISITION EFFORTS:

 

The Company continues its efforts to raise capital to support operations and growth, and is actively searching acquisition or merger with another company that would complement AOXY or increase its earnings potential. During this period, the Company has been in discussion with Companies looking to be acquired. AOXY has not negotiated any terms nor proposed any acquisitions of any of these companies that have been accepted. In addition, the Company is in discussion with potential lending institutions to assist in financing any proposed acquisition. The Company expects difficulty in financing the growth of the increased business or acquisition and has been concentrating on raising capital and/or obtaining a line of credit.

 

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk:

 

Smaller reporting companies are not required to provide the information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

We conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer who is also our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures”, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Acting Chief Financial Officer concluded as of March 31, 2019 that our disclosure controls and procedures were not effective at ensuring that the material information required to be disclosed in the Exchange Act reports is recorded, processed, summarized and reported as required in applicable SEC rules and forms.

 

During the six month period ended March 31, 2019, there were no changes in our internal control over financial reporting identified in connection with managements evaluation of the effectiveness of our internal control over the financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

 

 
13
 
Table of Contents

 

PART II

 

ITEM 1: LEGAL PROCEEDINGS

 

During the period ending March 31, 2019, there were pending or threatened legal actions as follows:

 

None

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None

 

ITEM 5. OTHER INFORMATION

 

None

 

ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K

 

During the nine-month period ending March 31, 2019, the Company filed no reports on Form 8-K

 

Exhibit Number

 

Description of the Document

 

 

 

3.1

 

Certificate of Incorporation as Amended and filed with the Secretary of State of Delaware effective on December 5, 2014(1)

3.2

 

Bylaws.(1)

31.1

 

Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

 

Certification of Chief Executive Officer in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of Chief Financial Officer in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

 

XBRL Instance

101.SCH

 

XBRL Taxonomy Extension Schema Document

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

XBRL Taxonomy Extension Labels Linkbase Document

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

________________

(1)

Filed as an exhibit to the Company’s 8-K filed with the SEC on December 5, 2014 and incorporated herein by reference.

 

 
14
 
Table of Contents

 

SIGNATURE

 

In accordance with the requirements of the Exchange Act, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

Date: April 17, 2019 By: /s/ Robert E. Wolfe

 

 

Robert E. Wolfe

 
   

Chairman of the Board and

Chief Executive Officer and

Principal Financial Officer

 

 

 
15